Flybridge Capital Partners β 2023 Investments
4 investments dated 2023 Β· listed companies and verified rows first Β· show all
Provides AI-powered tools for manufacturing and factory operations, including a chat assistant for troubleshooting, configurable AI agents, automated label validation, hands-free note-taking, and visual defect inspection.
Advanced ManufacturingAI & Machine LearningEnterprise SoftwareBoston, US
Yuval Itzhak Gonczarowski(Executive Officer, Director)Peter Flint(Director)
Co-investorsAtlassian VenturesFounder CollectiveNFXTwo Lanterns Venture PartnersArgon VenturesMitsubishi Electric Corporation+2 more
Nalu Bio develops an AI-powered drug discovery platform targeting the endocannabinoid system to create therapeutics for inflammatory, immune, and metabolic diseases.
AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US
Caitlyn Krebs(Co-founder + CEO)Phyllis Whiteley(Co-founder + Board Member)Randall Ussery(Co-founder + Board Member)Phyllis E. Whiteley(Executive Officer, Director)Randall S. Ussery(Director)Howard Goodwin(Director)
Co-investorsBonaventure Equity, LLCPortfoliaGolden Seeds
New York, US
Julian Herwitz(Executive Officer, Director, Promoter)Natasha Reddy(Executive Officer, Director, Promoter)
Portkey provides an AI gateway and LLMOps platform that gives AI teams unified access to 1,600+ language models, along with observability, governance, prompt management, and security guardrails.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSan Francisco, US
Rohit Agarwal(Executive Officer, Director)Ayush Garg(Executive Officer, Director)
Co-investorspeercheque
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.